BioTelemetry (NASDAQ: BEAT) is a wireless medical technology company focused on the delivery of health information to improve quality of life and reduce the cost of care. The company provides cardiac monitoring services, original equipment manufacturing with a primary focus on cardiac monitoring devices, and centralized cardiac core laboratory services. It was founded in 1994 and is based in Malvern, Pennsylvania. On December 18th, 2020, BioTelemetry was acquired by Philips.
Research containing BioTelemetry
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned BioTelemetry in 1 CB Insights research brief, most recently on May 6, 2021.
Expert Collections containing BioTelemetry
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
BioTelemetry is included in 2 Expert Collections, including Digital Health.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.
BioTelemetry has filed 4 patents.
Sensors, Physiology, Diabetes, Cardiology, Electrical engineering
Sensors, Physiology, Diabetes, Cardiology, Electrical engineering
Latest BioTelemetry News
Aug 30, 2023
Country scope Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States Report coverage Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends Market Consolidation Through Product Enhancements and Acquisitions is Expected to Fuel the Growth of Global Telemedicine Market Growth in Upcoming Years: The consolidation of the telemedicine industry through the strengthening of product offerings is an emerging trend followed by prime telemedicine companies. Increasing patient population and rising awareness toward technologies, the companies are to expand their manufacturing capabilities. This factor has led to geographic diversification, therapeutic and development expertise building, enormous capital generation, and steady technical resource availability among the industry giants, which helps them meet the requirement of healthcare facilities and patients suffering from chronic diseases, such as cancer, autoimmune treatment, and blood disorders, dental diseases, so rising demand of mobile health are rising directly. In August 2020, AMD partnered with iTelemed, an Ontario-based company providing virtual healthcare solutions. The partnership is aimed at catering to the unmet healthcare needs of the marginalized populations in Canada during the COVID-19 pandemic. Furthermore, in July 2020, Teladoc Health, Inc. acquired InTouch Health, US. This acquisition would Teladoc Health to establish a leading position in the virtual care industry by providing a full range of acuity from chronic care to critical an everyday care. Similarly, in June 2020, Philips launched the Avalon CL Fetal and Maternal Pod & Patch for remote monitoring for the consumers in the US, Europe, Australia, New Zealand, and Singapore to support fetal and maternal monitoring. In 2020, BioTelemetry acquired the On Demand remote patient monitoring (RPM) and coaching platform operated by Envolve People Care, Inc., a subsidiary of Centene Corporation. This acquisition helps BioTelemetry in expanding its current suite of acute care connected health products and services, focusing specifically on diabetes, hypertension, and chronic heart failure, with the addition of chronic RPM and coaching solutions. Impact of COVID-19 Pandemic on Global Telemedicine Market: As the number of COVID-19–infected patients increased, population using computers and tablets for telemedicine also increased, which also reduced staff exposure in ambulances and hospitals. Telemedicine has experienced a huge surge in adoption over the past few months, during the coronavirus pandemic. With people locked down at home, it has become the 'new normal' way of accessing healthcare. It is expected that demand for these services increased dramatically globally in COVID-19 pandemic, as the shares of one telehealth provider, Teladoc Health Inc., increased almost 50% since the start of 2020. Hospitals and health systems also encouraged people with suspected COVID-19 symptoms to use telehealth services to limit people's flow to already crowded emergency rooms and doctor surgeries. Therefore, the growing demand for telemedicine during COVID-19 worldwide is likely to boost the growth of the telemedicine market. Healthcare Fraud and Rising Data Security Concerns is Hampering the Growth of the Global Telemedicine Market Growth: Healthcare fraud is a critical concern associated with telehealth and telemedicine. Non-eligible or non-listed healthcare providers may conduct incorrect coding and billing for false claims, or they might use physicians’ name and account to collect payments from insurance companies. Healthcare fraud is a fraudulent enterprise carried out by a small number of deceptive health-care providers and organized crime groups. Health insurance fraud, opioid fraud, prescription drug diversion, and medical identity theft are among the key types of healthcare fraud. As per the Global Health Care Anti-Fraud Network, ~US$ 260 billion, i.e., ~6% of the global total health care expenditure is lost to fraud. This amount is almost equal to the GDP of countries such as Finland or Malaysia. Moreover, the tele-apps collect and analyze health data of their customers to improve automated digital services and solutions. Digital enterprises usually possess the right to use the consumer data for commercial and marketing purposes. Furthermore, there are many legal issues associated with telemedicine. A physician can be held liable for not acting upon a patient’s request for medical attention. If a telemedicine doctor fails to respond to the requests for medical attention and patients suffer further complications, it is possible that a doctor-patient relationship would be deemed to exist and the physician would be held liable. The digital health setups lack clarity regarding whether the physician has a duty to respond to treatment requests or to tell the patient if he or she is unable to support them for whatever reason. Many consumers are likely to be concerned about this situation, as they may be unable to share confidential health details. Directly Purchase this Report at https://www.theinsightpartners.com/buy/TIPRE00018287 Global Telemedicine Market: Competitive Landscape Allscripts Healthcare, LLC, Cerner Corporation, Cisco Systems, Inc., Eagle Telemedicine, Honeywell International Inc., McKesson Corporation, Koninklijke Philips N.V., AMD Global Telemedicine, Inc., American Well, Teladoc Health, Inc., and Insight are a few of the key companies operating in the telemedicine market. The market leaders focus on new product launches, expansion and diversification, and acquisition strategies, which allow them to access prevailing business opportunities. Global Telemedicine Market - Key Industry Dynamics: Drivers Increasing Prevalence of Chronic and Lifestyle-Associated Diseases Restraints Barriers to Telemedicine in Rural Areas and Developing Countries Lack of Universal Reimbursement Policies Opportunities Future Trends Recent Developments: In June 2020, Philips reported that it has re-joined forces with the American Telemedicine Association (ATA) to help advance the industry's implementation of telehealth, highlighting its contribution to linking treatment through acute, post-acute, and home care environments. The ongoing partnership highlights the increasing adoption and traction of telehealth in the context of COVID-19, as well as the need to communicate the exponential transition to telehealth capability. In October 2019, Cerner Corporation announced a formal arrangement to establish a wholly owned subsidiary of AbleVets, a strategic IT advisory and engineering company. Cerner would gain ever more size and technological experience in developing and executing modernization solutions, especially in the federal space, as a result of its acquisition of the Washington, DC-based business. The deal is expected to close in the fourth quarter, according to the firms. Global Telemedicine Market: Segmental Overview Based on product and service, the telemedicine market is segmented into software and hardware, tele-consulting, tele-monitoring, and tele-education/training. In 2020, the software and hardware segment held the largest telemedicine market share. However, the tele-consulting services segment is expected to grow at highest CAGR during the forecast period. Based on type, the telemedicine market is segmented into telehospital and telehome. In 2020, the telehospital segment held the largest market share of the telemedicine market, by type. However, the demand for telehome is also expected to grow at the fastest rate during the coming years. Based on specialty, the telemedicine market is segmented cardiology, gynecology, orthopedics, neurology mental health (psychiatry) and others. In 2020, the mental health segment held considerable share of the market, by specialty. Based on delivery mode, the telemedicine market is segmented into mobile, web, and call centers. In 2020, the mobile segment held the largest share of the market, by delivery mode. Report Spotlights: Business growth strategies adopted by developed and developing markets Quantitative analysis of the telemedicine market from 2021 to 2028 Estimation of global demand for telemedicine PEST analysis to illustrate the efficacy of buyers and suppliers operating in the industry Recent developments to understand the competitive market scenario Market trends and outlook as well as factors driving and restraining the growth of the telemedicine market Assistance in the decision-making process by highlighting market strategies that underpin commercial interest, leading to the market growth Size of the telemedicine market size at various nodes Detailed overview and segmentation of the market, as well as the telemedicine industry dynamics Size of the telemedicine market in various regions with promising growth opportunities Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):
BioTelemetry Frequently Asked Questions (FAQ)
When was BioTelemetry founded?
BioTelemetry was founded in 1994.
Where is BioTelemetry's headquarters?
BioTelemetry's headquarters is located at 1000 Cedar Hollow Road, Malvern.
What is BioTelemetry's latest funding round?
BioTelemetry's latest funding round is Acq - P2P.
How much did BioTelemetry raise?
BioTelemetry raised a total of $163.24M.
Who are the investors of BioTelemetry?
Investors of BioTelemetry include Philips, Sanderling Ventures, Tekla Capital Management, Flare Capital Partners, Biofrontier Partners and 6 more.
Who are BioTelemetry's competitors?
Competitors of BioTelemetry include Happitech, Peerbridge Health, Wellysis, Bardy Diagnostics, InfoBionic, CardioDiagnostics, Valor Healthcare, Upstream Rehabilitation, Hexoskin, U.S. Renal Care and 18 more.
Compare BioTelemetry to Competitors
LifeMasters is a disease management company providing programs and services that create health partnerships among individuals, their physicians and payors.
Nuvita is a corporate wellness solution. Nuvita is designed to improve employee health and reduce costs.
U.S. Renal Care provides in-center and at-home hemodialysis and peritoneal dialysis services for end-stage renal disease. The company also manages several acute-setting dialysis programs in conjunction with local community hospitals. It was founded in 2000 and is based in Plano, Texas.
Upstream Rehabilitation is a provider of outpatient rehabilitation services, including free-standing physical therapy clinics, outpatient rehabilitation management services and a member network of rehabilitation service providers. On December 5, 2019, Upstream Rehabilitation was acquired by Revelstoke Capital Partners. The terms of the transaction were not disclosed.
Concentra provides health care services. It offers vaccinations, occupational medicine, urgent care, physical therapy, test, and screening services. The company was founded in 1979 and is based in Addison, Texas.
AdhereHealth specializes in healthcare technology solutions supporting health plans, self-insured employers and other risk-bearing entities for medication adherence insights and improved healthcare outcomes. The company's Adhere platform touches consumers through advanced technologies, at-risk engagement services and home-delivered pharmacy.